Amantanium bromide
CAS: 58158-77-3
Ref. 3D-ICA15877
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- Amantanium bromide [INN]
- (2-(1-Tricyclo(3.3.1.1(3,7))decylcarbonyloxy)ethyl)decyldimethylammonium bromid
- Amantanil bromidum
- Bromure d'amantanium
- Bromuro de amantanio
- Decyl (2-hydroxyethyl)dimethylammonium bromide 1-adamantanecarboxylate
- Unii-K0435Hzq57
- N,N-dimethyl-N-{2-[(tricyclo[3.3.1.1~3,7~]dec-1-ylcarbonyl)oxy]ethyl}decan-1-aminium bromide
Amantadine is a prodrug that is hydrolyzed in vivo to form the active compound, amantadine triphosphate. It has antiviral activity against influenza virus and other RNA viruses. Amantadine is used to treat influenza A and B infections, as well as symptoms of influenza-like illness. This drug was approved by the FDA in 1967 and has been used as an alternative to neuraminidase inhibitors such as oseltamivir or zanamivir. Amantadine inhibits the release of neurotransmitters from nerve endings and may have some efficacy in treating neurodegenerative diseases such as Parkinson's disease, Huntington's disease, or Alzheimer's disease. Amantadine requires a water vapor to be effective because it is poorly soluble in water.
Propiedades químicas
Consulta técnica sobre: 3D-ICA15877 Amantanium bromide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
